Investors were disappointed with Pro Medicus Limited's ( ASX:PME ) recent earnings release. Our analysis found ...

This tech stock is being sold off again on Thursday despite reporting record results. The post Pro Medicus shares crash 20% on results day appeared first on The Motley Fool Australia.

What are the early trends we should look for to identify a stock that could multiply in value over the long term? Typically, ...

PME dropped more than 20% on revenue and dividend misses, even as NPAT soars to $171m.

Fintel reports that on April 7, 2025, BELL POTTER SECURITIES downgraded their outlook for Pro Medicus (ASX:PME) from Buy to Hold. As of April 2, 2025, the average one-year price target for Pro Medicus ...

The latest update is out from Pro Medicus Limited ( (AU:PME)). Pro Medicus Limited has disclosed a minor change in the shareholding of Director Sam Aaron Hupert, who has increased his direct interest ...

The latest announcement is out from Pro Medicus Limited ( (AU:PME)). Pro Medicus Limited has announced an update regarding its ongoing on-market buy-back program, which involves the repurchase of its ...

AI-fuelled panic has smashed ASX tech stocks. Here’s what most investors missed — and how you can figure out what happens next.

Morgans thinks this beaten down tech stock could recover from its latest selloff. The post Why Pro Medicus shares could rebound over 100% appeared first on The Motley Fool Australia.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.